Olumiant 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP9CT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,933
Award facts
- Contract value 100% obligated
- $19,933.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,933.02 to AmerisourceBergen Drug Corp for the supply of Olumiant 4 mg tablets (30-count units) on February 4, 2026, with completion targeted for February 5, 2026. This non-set-aside, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting the federal government's medical supply requirements for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive $999,999,999.00 indefinite delivery contract with the Defense Logistics Agency Troop Support Medical, which extends through December 31, 2031. The parent IDC serves as a global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis and certain other inflammatory conditions, reflecting the scope of specialty pharmaceuticals AmerisourceBergen delivers to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FP9CT?
SPE2DR26FP9CT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FP9CT worth?
The government has obligated $19,933 on SPE2DR26FP9CT.
Is contract SPE2DR26FP9CT an order under another contract?
Yes. SPE2DR26FP9CT is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9CT competed?
The extent of competition for SPE2DR26FP9CT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award